Mg-Ca-Zn magnesium alloy and preparation method and application thereof

By adding Ca and Zn elements to magnesium alloys and using heat treatment and low-temperature and low-speed extrusion technology to form the Ca2Mg6Zn3 phase, the shortcomings in strength, plasticity and corrosion resistance of existing magnesium alloy materials are solved, and high corrosion resistance is achieved. Good mechanical properties, suitable for orthopedic implantable medical devices.

CN118957372APending Publication Date: 2024-11-15NEW MATERIAL INST OF SHANDONG ACADEMY OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411015586.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-26
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing medical magnesium alloy materials have shortcomings in strength, plasticity and corrosion resistance, which are difficult to meet the needs of orthopedic implant materials, especially in avoiding challenges in secondary surgery and osteoporosis.

Method used

By adding Ca and Zn elements to the magnesium alloy, the Zn elements are uniformly dissolved by heat treatment technology, and the grains are refined and the Ca2Mg6Zn3 phase is formed by reducing the electrode potential difference between the matrix and the second phase and suppressing electricity Sometimes corrosion improves the strength, plasticity and corrosion resistance of the material.

Benefits of technology

It achieves high corrosion resistance and good mechanical properties of magnesium alloys, including the improvement of tensile yield strength, tensile strength and elongation after break, while reducing the corrosion rate and stress shading effect. It is suitable for orthopedic implantation medical devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118957372A_ABST
    Figure CN118957372A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of metal materials and processing, and relates to an Mg-Ca-Zn magnesium alloy and a preparation method and application thereof. The magnesium alloy comprises the following components in percentage by mass: 1.7%-2.3% of Ca, 1.21%-1.50% of Zn and the balance of Mg and inevitable impurities. The preparation method of the magnesium alloy comprises the following steps: uniformly and solidly dissolving Zn into a magnesium alloy matrix through a heat treatment process; grains are refined through low-temperature low-speed extrusion and dynamic recrystallization; crushing the Mg2Ca phase through a mechanical method; and finally, a natural aging process is combined, precipitation of the Zn element is promoted to form a Ca2Mg6Zn3 phase, the galvanic corrosion effect between a second phase and a matrix is weakened, and the strength, plasticity and corrosion resistance of the magnesium alloy are improved. The prepared Mg-Ca-Zn magnesium alloy has a good application prospect in the field of implantation medical instruments such as bone nails and bone lamellas.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of metal materials and processing, and specifically relates to a Mg-Ca-Zn magnesium alloy and a preparation method and application thereof. Background Art

[0002] Magnesium alloy is an alloy composed of magnesium as the matrix and other elements. It has the advantages of low density, high specific strength, large specific elastic modulus, good heat dissipation, good shock absorption, greater impact load bearing capacity than aluminum alloy, and resistance to organic and alkali corrosion. It is used in aviation, aerospace, transportation, chemical industry, and rocket fields. With the increase in traffic accidents, industrial accidents and the aging of the population, the market demand and development potential of orthopedic implant materials are growing. Orthopedic implant materials include stainless steel, titanium alloy, magnesium alloy, ceramic composite materials and polymer materials. Most implant materials require secondary surgery to remove, which not only increases the patient's pain and infection risk, but also generates additional costs.

[0003] Degradable implant materials such as magnesium alloys and polymers can gradually degrade in the body after bone recovery, effectively avoiding the problem of secondary surgery. However, polymer degradable implant materials have low strength and stiffness, poor load-bearing capacity, and limited application occasions. Traditional orthopedic implant metal materials (such as stainless steel and titanium alloys) have high stiffness (such as stainless steel about 200GPa, titanium alloy about 110GPa, bone 3~20GPa) and high strength (such as stainless steel 170~310MPa, titanium alloy 750~1100MPa, bone 130~180MPa), and produce obvious stress shielding effect after implantation, resulting in osteoporosis of bone tissue due to lack of mechanical stimulation during the recovery process.

[0004] Magnesium metal has good biocompatibility and the ability to promote fracture healing. At the same time, its strength and stiffness (pure magnesium has a yield strength of 65-100 MPa and a stiffness of 45 GPa) are close to those of bones, which can significantly reduce the stress shielding effect of traditional metal implant materials. Therefore, it has good development potential in the field of degradable implant materials. High-purity magnesium has good corrosion resistance, and its corrosion rate in 3.5% NaCl aqueous solution is about 0.3 mm / y, but its strength is relatively low. Ca and Zn are essential trace elements for the human body, which contribute to the growth and repair of bone tissue and are ideal alloying elements.

[0005] At present, although a lot of work has been done on composition optimization and forming process optimization of Mg-Ca-Zn magnesium alloys, because the strength and plasticity of traditional metal materials have an "inverted" relationship, and the high residual stress of low-temperature formed metal parts easily leads to a decrease in corrosion resistance, so far, medical magnesium alloy materials and forming processes with good strength, plasticity and corrosion resistance have not been obtained. Summary of the invention

[0006] The purpose of the present invention is to provide a Mg-Ca-Zn magnesium alloy and a preparation method and application thereof, wherein the Zn element is uniformly dissolved in the magnesium alloy matrix through a heat treatment process; the grains are refined and the Mg2Ca phase is mechanically crushed by dynamic recrystallization using low-temperature and low-speed extrusion; finally, natural cooling is performed so that higher-density crystal defects promote the precipitation of the Zn element around the second phase (Mg2Ca phase) to form a Ca2Mg6Zn3 phase, thereby weakening the galvanic corrosion between the second phase and the matrix and improving the strength, plasticity and corrosion resistance of the material.

[0007] In order to achieve the above object, the present invention is implemented through the following technical solutions:

[0008] In a first aspect, an embodiment of the present invention provides a Mg-Ca-Zn magnesium alloy, which comprises, by mass percentage, 1.7 to 2.3 wt.% Ca, 1.21 to 1.50 wt.% Zn, and the remainder being Mg and unavoidable impurities; the total amount of the impurities is not higher than 0.03 wt.%, wherein: Fe<0.02 wt.%, Cu<0.002 wt.%, Ni<0.002 wt.%.

[0009] In some other embodiments, the Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 2.1-2.3wt.% Ca, 1.21-1.30wt.% Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0010] In some other embodiments, the Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 2.1wt.% Ca, 1.25wt.% Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0011] In a second aspect, an embodiment of the present invention provides a method for preparing a Mg-Ca-Zn magnesium alloy, comprising the following steps:

[0012] S1, mixing ingredients: mixing pure Mg, pure Ca and pure Zn according to the composition of the Mg-Ca-Zn magnesium alloy described in the first aspect;

[0013] S2, melting and casting: melting, slag removal, standing and pouring into ingots;

[0014] S3, heat treatment: treating the ingot prepared in S2;

[0015] S4, extrusion: extrusion at 300-350℃ followed by cooling.

[0016] In some other embodiments, in S1, the purity of Mg and Zn is greater than 99.95%, and the purity of Ca is greater than 99%.

[0017] In some other embodiments, in S2, the smelting is carried out under a CO2+SF6 mixed gas, and pure Mg, pure Ca, and pure Zn are melted in sequence at 720-760°C for 40-60 minutes;

[0018] Preferably, the volume ratio of CO2 to SF6 in the CO2+SF6 mixed gas is (100-200):1;

[0019] The standing still step comprises stirring for 5 to 20 minutes after removing the slag and then keeping the temperature at room temperature for 20 to 40 minutes;

[0020] The pouring temperature is 680-700°C.

[0021] In some other embodiments, in S3, the heat treatment is carried out at 350-440° C. for 2-64 hours.

[0022] In some other embodiments, in S4, the extrusion speed is 0.01-0.2 mm / ; and the extrusion ratio is 40-80.

[0023] In a third aspect, an embodiment of the present invention provides an application of the Mg—Ca—Zn magnesium alloy described in the first aspect in an implantable medical device.

[0024] In some other embodiments, the implanted medical device is a bone screw or a bone plate.

[0025] The beneficial effects of the above embodiments of the present invention are as follows:

[0026] (1) The present invention adds Ca and Zn elements to the magnesium alloy, utilizes the lower corrosion potential of Ca element, the lower solid solubility in the magnesium alloy and the high corrosion resistance of Zn element, regulates the morphology and distribution of the second phase (Mg2Ca) in the magnesium alloy structure, forms a Ca2Mg6Zn3 phase with a potential close to that of the matrix electrode, reduces the electrode potential difference between the metal matrix and the second phase, inhibits galvanic corrosion, and forms a dense oxide film, thereby obtaining a highly corrosion-resistant medical magnesium alloy.

[0027] (2) The present invention utilizes high-density crystal defects formed by low-speed extrusion to promote the precipitation of the second phase along the grain boundary, obtains micron or submicron grain size and the second phase, and improves the strength and plasticity of the material: wherein the tensile yield strength is ≥310MPa, the tensile strength is ≥325MPa and the elongation after fracture is ≥11%; the compressive yield strength is ≥300MPa. The yield strength ratio is >95%, and the compression / tensile yield strength ratio is >96%.

[0028] (3) The Mg2Ca phase contained in the traditional Mg-Ca alloy is very easy to corrode as an anode; while the Mg-Zn phase in the Mg-Zn(-Ca) alloy corrodes the magnesium alloy matrix as a cathode. Both have poor corrosion resistance and require further surface treatment to improve their corrosion resistance. The magnesium alloy of the present invention can greatly improve the corrosion resistance of the alloy (the corrosion rate in 3.5% NaCl aqueous solution is less than 0.3mm·y -1 , better than high purity magnesium).

[0029] (4) The present invention adds an appropriate amount of Zn (1.3% ± 0.1%) to the Mg-Ca alloy, significantly reducing the anisotropy of the critical shear stress (CRSS) of the basal, cylindrical and conical slip systems, and has good plastic forming ability at 300-350°C. The minimum extrusion temperature of the Mg-2.0wt%Ca binary alloy through an 800-ton horizontal extruder is 400°C (extrusion ratio 60). It can be seen that the magnesium alloy of the present invention can be extruded at a lower temperature and the lower extrusion speed avoids the material temperature rise caused by deformation work. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.

[0031] Figure 1 This is a microstructure picture of Mg-2.1wt%Ca-1.25wt%Zn prepared in Example 1 of the present invention;

[0032] Figure 2 This is a microstructure picture of Mg-1.0wt%Ca-1.0wt%Zn prepared in Comparative Example 2 of the present invention. DETAILED DESCRIPTION

[0033] An embodiment of the present invention provides a Mg-Ca-Zn magnesium alloy, which contains, by mass percentage, 1.7 to 2.3 wt.% Ca, 1.21 to 1.50 wt.% Zn, and the remainder is Mg and unavoidable impurities; the total amount of the impurities is not higher than 0.03 wt.%, wherein: Fe<0.02 wt.%, Cu<0.002 wt.%, Ni<0.002 wt.%.

[0034] In some other embodiments, the Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 2.1-2.3wt.% Ca, 1.21-1.30wt.% Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0035] In some other embodiments, the Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 2.1wt.% Ca, 1.25wt.% Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0036] The Mg-Ca-Zn magnesium alloy of the present invention forms Mg2Ca and Ca2Mg6Zn3 phases by adjusting the ratio of Ca and Zn elements, thereby inhibiting the generation of MgZn phase. The grains are refined, the electrode potential difference between the second phase and the magnesium alloy matrix is ​​weakened, and the mechanical properties and corrosion resistance of the material are improved. At the same time, the CRSS anisotropy of each slip plane of the alloy is improved, so that it has good forming ability within the range of 300 to 350°C.

[0037] The present invention also provides a method for preparing the above Mg-Ca-Zn magnesium alloy, comprising the following steps:

[0038] S1, batching: pure Mg, pure Ca and pure Zn are batched according to the composition of the Mg-Ca-Zn magnesium alloy according to any one of claims 1 to 3;

[0039] S2, melting and casting: melting, slag removal, standing and pouring into ingots;

[0040] S3, heat treatment: treating the ingot prepared in S2;

[0041] S4, extrusion: extrusion at 300-350℃ followed by cooling.

[0042] In some other embodiments, in S1, the purity of Mg and Zn is greater than 99.95%, and the purity of Ca is greater than 99%.

[0043] In some other embodiments, in S2, the smelting is carried out under a CO2+SF6 mixed gas, and pure Mg, pure Ca, and pure Zn are melted in sequence at 720-760°C for 40-60 minutes;

[0044] Preferably, the volume ratio of CO2 to SF6 in the CO2+SF6 mixed gas is (100-200):1;

[0045] The standing still step comprises stirring for 5 to 20 minutes after removing the slag and then keeping the temperature at room temperature for 20 to 40 minutes;

[0046] The pouring temperature is 680-700°C.

[0047] In some other embodiments, in S3, the heat treatment is carried out at 350-440° C. for 2-64 hours.

[0048] In some other embodiments, in S4, the extrusion speed is 0.01-0.2 mm / ; and the extrusion ratio is 40-80.

[0049] The present invention uses a heat treatment process to uniformly dissolve the Zn element into a magnesium alloy matrix; then uses low-temperature and low-speed extrusion to refine the grains through dynamic recrystallization and mechanically crush the Mg2Ca phase; finally, natural cooling allows higher-density crystal defects to promote the precipitation of the Zn element around the second phase (Mg2Ca phase) to form a Ca2Mg6Zn3 phase, weakening the galvanic corrosion between the second phase and the matrix, and improving the strength, plasticity and corrosion resistance of the material.

[0050] The embodiments of the present invention provide the application of the Mg-Ca-Zn magnesium alloy in implantable medical devices.

[0051] In some other embodiments, the implanted medical device is a bone screw or a bone plate.

[0052] The present invention will be further described in detail below in conjunction with specific embodiments. It should be noted that the specific embodiments are intended to explain the present invention rather than to limit it.

[0053] Example 1

[0054] A Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 2.1wt.% of Ca, 1.25wt.% of Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0055] The preparation method comprises the following steps:

[0056] S1, ingredients: weigh pure Mg, pure Ca and pure Zn according to the proportion of magnesium alloy components; the purity of metal Mg and Zn is greater than 99.95%, and the purity of metal Ca is greater than 99%.

[0057] S2, melting and casting: melt the prepared magnesium alloy raw materials in the protection condition of CO2+SF6 mixed gas (ratio 100:1) at 740℃, pure Mg, pure Ca and pure Zn in turn, and keep warm for 40min; refine and stir for 5min, and keep warm and stand for 30min; pour into ingots at 680℃.

[0058] S3, heat treatment: keep at 420℃ for 24h.

[0059] S4, extrusion: using a horizontal extruder, extrusion molding at 330°C at a speed of 0.1 mm / s, with an extrusion ratio of 60; and then naturally cooling.

[0060] Figure 1The microstructure picture of the magnesium alloy prepared in Example 1 of the present invention shows that a micrometer-scale grain size and a fine dispersion of the second phase are obtained, so the relevant properties are good.

[0061] Example 2

[0062] A Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 1.7wt.% of Ca, 1.21wt.% of Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0063] The preparation method comprises the following steps:

[0064] S1, ingredients: weigh pure Mg, pure Ca and pure Zn according to the proportion of magnesium alloy components; the purity of metal Mg and Zn is greater than 99.95%, and the purity of metal Ca is greater than 99%.

[0065] S2, melting and casting: melt the prepared magnesium alloy raw materials in the protection condition of CO2+SF6 mixed gas (ratio 100:1) at 730℃, pure Mg, pure Ca and pure Zn in turn, and keep warm for 50min; refine and stir for 10min, and keep warm and stand for 40min; pour into ingot at 690℃.

[0066] S3, heat treatment: keep at 410℃ for 22h.

[0067] S4, extrusion: using a horizontal extruder, extrusion molding at 320°C at a speed of 0.05 mm / s, with an extrusion ratio of 60; and then naturally cooling.

[0068] Example 3

[0069] A Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 2.3wt.% of Ca, 1.50wt.% of Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0070] The preparation method comprises the following steps:

[0071] S1, ingredients: weigh pure Mg, pure Ca and pure Zn according to the proportion of magnesium alloy components; the purity of metal Mg and Zn is greater than 99.95%, and the purity of metal Ca is greater than 99%.

[0072] S2, melting and casting: melt the prepared magnesium alloy raw materials in the protection condition of CO2+SF6 mixed gas (ratio 100:1) at 740℃, pure Mg, pure Ca and pure Zn in turn, and keep warm for 50min; refine and stir for 10min, and keep warm and stand for 40min; pour into ingot at 690℃.

[0073] S3, heat treatment: keep at 430℃ for 20h.

[0074] S4, extrusion: using a horizontal extruder, extrusion molding at 335°C at a speed of 0.08 mm / s, with an extrusion ratio of 60; and then naturally cooling.

[0075] Comparative Example 1

[0076] The AZ31 magnesium alloy contains, by mass percentage, 3.1 wt.% Al, 1.0 wt.% Zn, and the balance is Mg. The preparation process is the same as that of Example 1, which will not be repeated here.

[0077] Comparative Example 2

[0078] A Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 1.0wt.% Ca, 1.0wt.% Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg. The preparation process is the same as that of Example 1 and will not be repeated here.

[0079] Figure 2 The microstructure picture of the magnesium alloy prepared in Comparative Example 2 of the present invention shows that, compared with Example 1, the grains of the magnesium alloy in Comparative Example 2 are slightly coarse and the second phase is relatively small, which is insufficient to inhibit the growth of recrystallized grains, and thus the overall performance is poor.

[0080] Comparative Example 3

[0081] A Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 2.5wt.% Ca, 1.0wt.% Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0082] The preparation process is different from that of Example 1 in that, in step S4, when the extrusion ratio is 60 and the extrusion speed is 0.08 mm / s, extrusion forming cannot be performed at a temperature of 300-350°C, and the extrusion forming can only be completed by increasing the extrusion temperature to 380°C.

[0083] Comparative Example 4

[0084] A Mg-Ca-Zn magnesium alloy comprises, by mass percentage, 2.0wt.% of Ca, 1.0wt.% of Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

[0085] The preparation process is different from that of Example 1 in that, in step S4, extrusion cannot be performed at an extrusion ratio of 60, a speed of 0.08 mm / s, and a temperature of 300-350°C. The extrusion temperature must be raised to 380°C to complete the extrusion.

[0086] Comparative Example 5

[0087] A Mg-Ca-Zn magnesium alloy having the same composition as that in Example 1.

[0088] The difference between the preparation process and Example 1 is that the S4 extrusion step is: using a horizontal extruder, extruding at a speed of 2 mm / s at 400° C., with an extrusion ratio of 60; and then cooling naturally.

[0089] Table 1 shows the mechanical properties and corrosion rates of the magnesium alloys in Examples 1-3 and Comparative Examples 1-5. The mechanical properties test method is based on GB T 228.1-2021 and GB T 7314-2017 standards; the corrosion rate is the test result of the magnesium alloy sample being immersed in a 3.5% NaCl aqueous solution at room temperature for 48 hours, and after corrosion, chromic acid (200 g / L CrO3+10 g / L AgNO3) is used to clean the corrosion products on the sample surface, according to ASTM G1-90 standard.

[0090] Corrosion rate = (K×W) / (A×t×ρ) (1)

[0091] Where, K = 87600, W is the weight loss (g), A is the surface area of ​​the sample (cm 2 ), t is the immersion time (h), ρ is the sample density (g / cm 3 ).

[0092] Table 1 Mechanical properties and corrosion rates of magnesium alloys

[0093]

[0094] It can be seen from Table 1 that the corrosion rate of the Mg-Ca-Zn magnesium alloys of Examples 1 to 3 of the present invention is less than 0.3 mm·y -1 , the corrosion resistance is better than that of high-purity magnesium; its tensile yield strength is ≥310MPa, tensile strength is ≥325MPa, compressive yield strength is ≥300MPa, and elongation after fracture is ≥11%. It has a good yield strength ratio and small tensile / compression asymmetry. The magnesium alloys of Comparative Examples 1 and 2 have a large difference in composition from the magnesium alloys of Examples 1 to 3. Although the preparation methods are the same, the corrosion rate is significantly increased. The magnesium alloys of Comparative Examples 3 and 4 have a small difference in composition from the magnesium alloys of Examples 1 to 3, but the forming difficulty is greater, the forming temperature is significantly increased, and the corrosion rate is also increased compared to high-purity magnesium, resulting in weaker corrosion resistance than pure magnesium. The forming temperature and speed used in Comparative Example 5 are both higher than those in Example 1, and the corrosion resistance is significantly reduced.

[0095] In summary, the medical magnesium alloy provided by the present invention has good comprehensive mechanical properties - high strength, good elongation and corrosion resistance, and can be used in the field of implantable medical devices such as bone nails and bone plates.

[0096] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A Mg-Ca-Zn magnesium alloy, characterized in that: In terms of mass percentage, it contains 1.7-2.3wt.% Ca, 1.21-1.50wt.% Zn, and the balance is Mg and inevitable impurities; the total amount of the impurities is not higher than 0.03wt.%, among which: Fe<0.02wt.%, Cu<0.002wt.%, Ni<0.002wt.%.

2. The Mg-Ca-Zn magnesium alloy according to claim 1, characterized in that: In terms of mass percentage, it comprises 2.1-2.3wt.% Ca, 1.21-1.30wt.% Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

3. The Mg-Ca-Zn magnesium alloy according to claim 2, characterized in that: In terms of mass percentage, it comprises 2.1wt.% Ca, 1.25wt.% Zn, Fe<0.001wt.%, Cu<0.001wt.%, Ni<0.001wt.%, and the balance is Mg.

4. A method for preparing a Mg-Ca-Zn magnesium alloy, characterized in that: The following steps are involved: S1, batching: pure Mg, pure Ca and pure Zn are batched according to the composition of the Mg-Ca-Zn magnesium alloy according to any one of claims 1 to 3; S2, melting and casting: melting, slag removal, standing and pouring into ingots; S3, heat treatment: treating the ingot prepared in S2; S4, extrusion: extrusion at 300-350℃ followed by cooling.

5. The method for preparing the Mg-Ca-Zn magnesium alloy according to claim 4, characterized in that: In S1, the purity of Mg and Zn is greater than 99.95%, and the purity of Ca is greater than 99%.

6. The method for preparing the Mg-Ca-Zn magnesium alloy according to claim 4, characterized in that: In S2, the smelting is carried out under a mixed gas of CO2+SF6, and pure Mg, pure Ca and pure Zn are melted in sequence at 720-760°C for 40-60 minutes; Preferably, the volume ratio of CO2 to SF6 in the CO2+SF6 mixed gas is (100-200):1; The standing still step comprises stirring for 5 to 20 minutes after removing the slag and then keeping the temperature at room temperature for 20 to 40 minutes; The pouring temperature is 680-700°C.

7. The method for preparing the Mg-Ca-Zn magnesium alloy according to claim 4, characterized in that: In S3, the heat treatment is carried out at 350-440°C for 2-64 hours.

8. The method for preparing the Mg-Ca-Zn magnesium alloy according to claim 4, characterized in that: In S4, the extrusion speed is 0.01-0.2 mm / ; the extrusion ratio is 40-80.

9. Use of the Mg-Ca-Zn magnesium alloy according to any one of claims 1 to 3 in implantable medical devices.

10. The use according to claim 9, characterized in that The implanted medical device is a bone nail or a bone plate.